Novartis Home

The Novartis Compound Library provides automated storage for experiments.

At Novartis, we are reimagining medicine

Novartis statement on Zolgensma

Novartis stands behind Zolgensma® for the treatment of children less than 2 years of age with spinal muscular atrophy.

Read More

Hardwiring the future

A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.

Read More

Novartis Financial Results – Q2 2019

Novartis announced the company’s financial results for the second quarter and first half of 2019.

Read More

Transparency